Insider Trading Review: Corvus Pharmaceuticals, Inc. $CRVS

956d43b568cb7c6df4669b34fd9537d2

Corvus Pharmaceuticals, Inc. (CRVS) insider have most recently took part in a trading activity. On Jun 23, 2017 Novo Holdings A/s, 10% Owner bought 20,000 shares having total worth of $219,000 at the price of $10.95 per share, following the transaction a total of 3,244,046 shares owned by Novo Holdings A/s.

The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 3 times by insiders. an employee of the company was the buyer in 3 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 1 0 -12.73%
12 Month 3 0 -14.88%

Shares of Corvus Pharmaceuticals, Inc. (CRVS) traded up 7.35% on Jun 26, 2017, hitting $12.13. 139,653 shares of the company’s stock traded hands. Corvus Pharmaceuticals, Inc. has a 52 week low of $9.44 and a 52 week high of $21.37. The company’s market cap is $344 million.

Corvus Pharmaceuticals, Inc. (CRVS) last announced its earnings results on Mar 10, 2017. The company reported -0.55 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.57 by $0.02.

2017-03-10
earnings per share -0.55
Revenue(M) 0

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.